Indianapolis, IN, United States of America

Alan Greenburg

This inventor holds 25 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in Diabetes Management. Top assignees: Roche Diabetes Care, Inc., Roche Diagnostics Operations, Inc., Roche Diagnostics International Ag. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan Greenburg. Retrieved from https://idiyas.com/inventor/alan-greenburg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 25 

% Patents Active = 92.0

 

 

Average Co-Inventor Count = 4.8

ph-index = 9

Forward Citations = 499(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Diabetes Management
Bolus Calculator
Glucose Data Analysis
Portable Analytical Device
Structured Collection Procedure
Hypoglycemia Detection
Insulin Pump Programming
Graphical User Interface
Risk-Based Control
Status Reporting
Dynamic Data Collection
Patient Data Interchange
25 patents (USPTO):Explore Patents

Title: Alan Greenburg: Innovator in Diabetes Management Solutions

Introduction

Alan Greenburg is a prominent inventor based in Indianapolis, Indiana, with an impressive portfolio of 24 patents. His innovative contributions primarily focus on diabetes management technologies, providing essential tools for individuals living with diabetes.

Latest Patents

Among his latest inventions is the "Handheld Diabetes Management Device with Bolus Calculator." This device provides a method for determining an allowable amount of blood glucose (bG) for a patient. The device integrates current bG measurements, target bG values, and correction factors based on historical data to optimize diabetes management. Another significant patent is the "Risk-Based Control-to-Range Blood Glucose Diabetes Management Device." This invention involves adjusting the basal rate of insulin from a therapy delivery device based on the risk associated with a patient's glucose state, offering a personalized approach to diabetes therapy.

Career Highlights

Throughout his career, Alan Greenburg has demonstrated a commitment to advancing diabetes care through patented innovations. His work has significantly impacted the field, providing healthcare professionals and patients with reliable tools to manage diabetes effectively.

Collaborations

Alan has collaborated with respected colleagues such as Paul J. Galley and Stefan Weinert, enhancing the quality and effectiveness of his projects. He has also made notable contributions while working with well-known companies, including Roche Diabetes Care, Inc. and Roche Diagnostics Operations, Inc., where he further developed cutting-edge technologies in diabetes management.

Conclusion

Alan Greenburg continues to be a vital figure in the invention of diabetes management solutions. His patents reflect his dedication to improving the lives of individuals with diabetes, embodying the spirit of innovation that drives progress in healthcare technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…